Fibrinogen concentrate in the treatment of severe bleeding after aortic aneurysm graft surgery

Thrombosis Research

Volumn 128, Issue SUPPL. 1, 2011, Pages

  Rahe Meyer, Niels ^a  

^a Clinic for Anesthesiology and Intensive Care Medicine   (Germany)

Author keywords

Aorta; Aortic aneurysm; Coagulopathy; Fibrinogen; Hemostasis; Surgery

Indexed keywords

FIBRINOGEN; FRESH FROZEN PLASMA; THROMBOCYTE CONCENTRATE;

ABDOMINAL AORTA ANEURYSM; ANEURYSM SURGERY; AORTIC ARCH SURGERY; AORTIC VALVE REPAIR; ASCENDING AORTA SURGERY; BLEEDING; BLOOD VOLUME; CARDIOPULMONARY BYPASS; DISEASE SEVERITY; ERYTHROCYTE TRANSFUSION; HUMAN; INDIVIDUALIZATION; PERIOPERATIVE COMPLICATION; PERIOPERATIVE PERIOD; PILOT STUDY; PRIORITY JOURNAL; REVIEW;

EID: 84855361631     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/S0049-3848(12)70005-1     Document Type: Article

References (23)

1. Gertler JP, Cambria RP, Brewster DC, Davison JK, Purcell P, Zannetti S, et al. Coagulation changes during thoracoabdominal aneurysm repair. J Vasc Surg 1996;24:936-45. (Pubitemid 26425698)
2. Blome M, Isgro F, Holger Kiessling A, Skuras J, Haubelt H, Hellstern P, et al. Relationship between factor XIII activity, fibrinogen, haemostasis screening tests and postoperative bleeding in cardiopulmonary bypass surgery. Thromb Haemost 2005;93:1101-7. (Pubitemid 40823515)
3. Kestin AC, Valeri CR, Khuri SF, Loscalzo J, Ellis PA, MacGregor H, et al. The platelet function defect of cardiopulmonary bypass. Blood 1993;82:107-17. (Pubitemid 23188753)
4. Levi M, Cromheecke ME, de Jonge E, Prins MH, de Mol BJ, Briët E, et al. Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints. Lancet 1999;354:1940-7.
5. Mannucci PM, Duga S, Peyvandi F. Recessively inherited coagulation disorders. Blood 2004;104:1243-52. (Pubitemid 39166494)
6. Casbard AC, Williamson LM, Murphy MF, Rege K, Johnson T. The role of prophylactic fresh frozen plasma in decreasing blood loss and correcting coagulopathy in cardiac surgery: a systematic review. Anaesthesia 2004;59:550-8. (Pubitemid 38744889)
7. Kamath S, Lip GYH. Fibrinogen: biochemistry, epidemiology and determinants. Q J Med 2003;96;711-29. (Pubitemid 37259361)
8. Sorensen B. The role of fibrinogen: a new paradigm in the treatment of coagulopathic bleeding. Thromb Res; in press.
9. O'Shaughnessy DF, Atterbury C, Bolton Maggs P, Murphy M, Thomas D, Yates S, et al. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol 2004;126:11-28. (Pubitemid 38859478)
10. Rossaint R, Bouillon B, Cerny V, Duranteau J, Fernández- Mondéjar E, Hunt BJ, et al. Management of bleeding following major trauma: an updated European guideline. Crit Care 2010;14:R52.
11. Kreuz W, Meili E, Peter-Salonen K, Dobrkovská A, Devay J, Haertel S, et al. Pharmacokinetic properties of a pasteurized fibrinogen concentrate. Transfus Apher Sci 2005;32:239-46. (Pubitemid 40804614)
12. Charbit B, Mendelbrot L, Samain E, Baron G, Haddaoui B, Keita H, et al. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost 2007;5:266-73. (Pubitemid 46139450)
13. Karlsson M, Ternström L, Hyllner M, Baghaei F, Nilsson S, Jeppsson A. Plasma fibrinogen level, bleeding, and transfusion after on-pump coronary artery bypass grafting surgery: a prospective observational study. Transfusion 2008;48:2152-8.
14. Fenger-Eriksen C, Ingerslev J, Sørensen B. Fibrinogen concentrate - a potential universal hemostatic agent. Expert Opin Biol Ther 2009;9:1325-33.
15. Kreuz W, Meili E, Peter-Salonen K, Haertel S, Devay J, Krzensk U, et al. Efficacy and tolerability of a pasteurised human fibrinogen concentrate in patients with congenital fibrinogen deficiency. Transfus Apher Sci 2005;32:247-53. (Pubitemid 40804615)
16. Peyvandi F, Kaufman RJ, Seligsohn U, Salomon O, Bolton-Maggs PH, Spreafico M, et al. Rare bleeding disorders. Haemophilia 2006;12(Suppl 3):137-42.
17. Rahe-Meyer N, Pichlmaier M, Haverich A, Solomon C, Winterhalter M, Piepenbrock S, et al. Bleeding management with fibrinogen concentrate targeting a high-normal plasma fibrinogen level: a pilot study. Br J Anaesth 2009;102:785-92.
18. Rahe-Meyer N, Solomon C, Winterhalter M, Piepenbrock S, Tanaka K, Haverich A, et al. Thromboelastometry-guided administration of fibrinogen concentrate for the treatment of excessive intraoperative bleeding in thoracoabdominal aortic aneurysm surgery. J Thoracic Cardiovasc Surg 2009;138:694-702.
19. Fenger-Eriksen C, Moore GW, Rangarajan S, Ingerslev J, Sørensen B. Fibrinogen estimates are influenced by methods of measurement and hemodilution with colloid plasma expanders. Transfusion 2010;50:2571-6.
20. Lang T, Johanning K, Metzler H, Piepenbrock S, Solomon C, Rahe-Meyer N, et al. The effects of fibrinogen levels on thromboelastometric variables in the presence of thrombocytopenia. Anesth Analg 2009;108:751-8.
21. Schöchl H, Nienaber U, Maegele M, Hochleitner G, Primavesi F, Steitz B, et al. Transfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy. Crit Care 2011;15:R83.
22. Bolliger D, Szlam F, Molinaro RJ, Rahe-Meyer N, Levy JH, Tanaka KA. Finding the optimal concentration range for fibrinogen replacement after severe haemodilution: an in vitro model. Br J Anaesth 2009;102:793-9.
23. Coppola L, Caserta F, De Lucia D, Guastafierro S, Grassia A, Coppola A, et al. Blood viscosity and aging. Arch Gerontol Geriatr 2000;31:35-42.